EUVIMEDEUVIMED entdecken
Crossref

Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data

Dianbo Liu, Karmel W Choi, Paulo Lizano, William Yuan, Kun-Hsing Yu, Jordan Smoller, Isaac Kohane

Schizophrenia Research · 2025

DOI: 10.1016/j.schres.2025.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2025. Verfasst von Dianbo Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; School of Medicine, National University of Singapore, Singapore; Colle…. Hauptthemen laut MEDLINE: Machine Learning, Electronic Health Records, Psychotic Disorders, Mental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Harvard Medical School, Massachusetts General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IMPORTANCE: The prevalence of severe mental illnesses (SMIs) in the United States is approximately 3 % of the whole population. The ability to conduct risk screening of SMIs at large scale could inform early prevention and treatment. OBJECTIVE: A scalable machine learning based tool was developed to conduct population-level risk screening for SMIs, including schizophrenia, schizoaffective disorders, psychosis, and bipolar disorders, using 1) healthcare insurance claims and 2) electronic health records (EHRs). DESIGN, SETTING AND PARTICIPANTS: Data from beneficiaries from a nationwide commercial healthcare insurer with 77.4 million members and data from patients from EHRs from eight academic hospitals based in the U.S. were used. First, the predictive models were constructed and tested using data in case-control cohorts from insurance claims or EHR data. Second, performance of the predictive models across data sources was analyzed. Third, as an illustrative application, the models were further trained to predict risks of SMIs among 18-year old young adults and individuals with substance associated conditions. MAIN OUTCOMES AND MEASURES: Machine learning-based predictive models for SMIs in the general population were built based on insurance claims and EHR. RESULTS: A total of 301,221 patients with SMIs and 2,439,890 control individuals were retrieved from the nationwide health insurance claim database in the U.S. A total of 59,319 patients with SMIs and 297,993 control individuals were retrieved from EHRs spanning eight different hospitals from a major integrated healthcare system in Massachusetts, U.S. The obtained predictive models for SMIs achieved AUCROC of 0.76, specificity of 79.1 % and sensitivity of 61.9 % on an independent test set of an all-age case-control cohort from insurance claim data, and AUCROC of 0.83, specificity of 85.1 % and sensitivity of 66.4 % using EHR data. The fine-tuned models for specific use case scenarios outperformed two rule based benchmark methods when predicting 12-month risk of SMIs among 18-year old young adults but had inferior performance to benchmark methods when predicting SMIs among individuals with substance associated conditions in claims data. CONCLUSION: Performance of our SMI prediction models constructed using health insurance claims or EHR data suggest feasibility of using real world healthcare data for large scale screening of SMIs in the general population. In addition, our analysis showed cross data source generalizability of machine learning models trained on real world healthcare data. Models constructed from insurance claims appear to be transferable to EHR cohorts and vice versa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningElectronic Health RecordsPsychotic DisordersMental DisordersSchizophreniaBipolar DisorderHumansMaleFemaleAdultYoung AdultAdolescentMiddle AgedUnited StatesCase-Control StudiesRisk Assessment

Stichwörter der Autor:innen

Real world healthcare dataScreeningSevere mental illnesses

Autor:innen und Institutionen

  • Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; School of Medicine, National University of Singapore, Singapore; College of Design and Engineering, National University of Singapore, Singap…
  • Center for Human Genetics Research, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Electronic address: Isaac_Kohane@hms.harvard.edu.

Förderung

  • Harvard Medical School
  • Massachusetts General Hospital

Zitieren

APA

Liu, D., Choi, K. W., Lizano, P., Yuan, W., Yu, K. H., Smoller, J., & Kohane, I. (2025). Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data. Schizophrenia Research. https://doi.org/10.1016/j.schres.2025.06.024

Vancouver

Liu D, Choi KW, Lizano P, Yuan W, Yu KH, Smoller J, et al. Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data. Schizophrenia Research. 2025. doi:10.1016/j.schres.2025.06.024

BibTeX
@article{Liu2025,
  author = {Liu, Dianbo and Choi, Karmel W and Lizano, Paulo and Yuan, William and Yu, Kun-Hsing and Smoller, Jordan and Kohane, Isaac},
  title = {Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data},
  journal = {Schizophrenia Research},
  year = {2025},
  doi = {10.1016/j.schres.2025.06.024}
}
Kostenlos starten →